Publications by authors named "Enric Garcia-Alzorriz"
The objective was to compare clinical characteristics, outcomes, and economic differences in complicated urinary tract infections (cUTI) caused by extensively drug-resistant Pseudomonas aeruginosa (XDR P. aeruginosa) and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (ESBL-K. pneumoniae).
View Article and Find Full Text PDFCorrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Front Pharmacol
March 2022
[This corrects the article DOI: 10.3389/fphar.2021.
View Article and Find Full Text PDFImpact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Front Pharmacol
November 2021
Article Synopsis
- Rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis are chronic autoimmune diseases that can lead to disability, affecting healthcare costs and resource use.
- The study aimed to determine how non-persistence (stopping treatment) with subcutaneous TNF inhibitors impacts healthcare costs for patients starting medications like adalimumab and etanercept over 12 months.
- Results showed that patients who did not stick to their SC-TNF treatment had significantly higher healthcare costs related to outpatient care, laboratory tests, and other medications compared to those who persisted with their treatment.
To estimate the incremental cost of nosocomial bacteremia according to the causative focus and classified by the antibiotic sensitivity of the microorganism.Patients admitted to Hospital del Mar in Barcelona from 2005 to 2012 were included. We analyzed the total hospital costs of patients with nosocomial bacteremia caused by microorganisms with a high prevalence and, often, with multidrug-resistance.
View Article and Find Full Text PDFAim: To calculate the incremental cost of nosocomial bacteremia caused by the most common organisms, classified by their antimicrobial susceptibility.
Methods: We selected patients who developed nosocomial bacteremia caused by Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa. These microorganisms were analyzed because of their high prevalence and they frequently present multidrug resistance.
Objective: To assess the hospital cost associated with colorectal cancer (CRC) treatment by stage at diagnosis, type of cost and disease phase in a public hospital.
Methods: A retrospective analysis was conducted of the hospital costs associated with a cohort of 699 patients diagnosed with CRC and treated for this disease between 2000 and 2006 in a teaching hospital and who had a 5-year follow-up from the time of diagnosis. Data were collected from clinical-administrative databases.